Detalhe da pesquisa
1.
North American Blastic Plasmacytoid Dendritic Cell Neoplasm Consortium: position on standards of care and areas of need.
Blood
; 141(6): 567-578, 2023 02 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36399715
2.
Conditioning intensity and peritransplant flow cytometric MRD dynamics in adult AML.
Blood
; 139(11): 1694-1706, 2022 03 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34995355
3.
Relative prognostic value of flow cytometric measurable residual disease before allogeneic hematopoietic cell transplantation for adults with MDS/AML or AML.
Am J Hematol
; 99(5): 862-870, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38380817
4.
2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party.
Blood
; 138(26): 2753-2767, 2021 12 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34724563
5.
Flotetuzumab as salvage immunotherapy for refractory acute myeloid leukemia.
Blood
; 137(6): 751-762, 2021 02 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32929488
6.
Relative impact of residual cytogenetic abnormalities and flow cytometric measurable residual disease on outcome after allogeneic hematopoietic cell transplantation in adult acute myeloid leukemia.
Haematologica
; 108(2): 420-432, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35924583
7.
Hyper-CVAD versus dose-adjusted EPOCH as initial treatment for adults with acute lymphoblastic leukemia.
Eur J Haematol
; 111(6): 863-871, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37670560
8.
Measurable residual disease monitoring in patients with acute myeloid leukemia treated with lower-intensity therapy: Roadmap from an ELN-DAVID expert panel.
Am J Hematol
; 98(12): 1847-1855, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37671649
9.
Cerebrospinal fluid flow cytometry and risk of central nervous system relapse after hyperCVAD in adults with acute lymphoblastic leukemia.
Cancer
; 128(7): 1411-1417, 2022 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34931301
10.
The present and future of measurable residual disease testing in acute myeloid leukemia.
Haematologica
; 107(12): 2810-2822, 2022 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36453518
11.
Characteristics and outcome of patients with acute myeloid leukaemia and t(8;16)(p11;p13): results from an International Collaborative Study.
Br J Haematol
; 192(5): 832-842, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33529373
12.
Survival of patients with newly diagnosed high-grade myeloid neoplasms who do not meet standard trial eligibility.
Haematologica
; 106(8): 2114-2120, 2021 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32646891
13.
Financial Implications of Early Hospital Discharge After AML-Like Induction Chemotherapy: A 4-Year Retrospective Analysis.
J Natl Compr Canc Netw
; : 1-10, 2021 Jun 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34161925
14.
A phase 1 trial of vadastuximab talirine combined with hypomethylating agents in patients with CD33-positive AML.
Blood
; 132(11): 1125-1133, 2018 09 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-30045838
15.
A phase 1 trial of vadastuximab talirine as monotherapy in patients with CD33-positive acute myeloid leukemia.
Blood
; 131(4): 387-396, 2018 01 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-29196412
16.
Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party.
Blood
; 131(12): 1275-1291, 2018 03 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-29330221
17.
Allogeneic hematopoietic cell transplantation improves outcome of adults with t(6;9) acute myeloid leukemia: results from an international collaborative study.
Haematologica
; 105(1): 161-169, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31004014
18.
Outpatient induction and consolidation care strategies in acute myeloid leukemia.
Curr Opin Hematol
; 26(2): 65-70, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30585894
19.
A real-world, cross-sectional, community survey of symptoms and health-related quality of life of adults with acute myeloid leukemia.
Future Oncol
; 15(16): 1895-1909, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-30912462
20.
Deep NPM1 Sequencing Following Allogeneic Hematopoietic Cell Transplantation Improves Risk Assessment in Adults with NPM1-Mutated AML.
Biol Blood Marrow Transplant
; 24(8): 1615-1620, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29684564